🇺🇸 FDA
Company

IDEAYA

IDEAYA Biosciences

IDYA pharma USA

Quick answer

IDEAYA is a pharma company (IDYA) headquartered in SOUTH SAN FRANCISCO, CA, USA with 9 tracked pipeline programs.

Pipeline (9)

project

Darovasertib

Uveal Melanoma

Phase 3 · small_molecule · active

2 trials project

IDE196

Metastatic Uveal Melanoma

Phase 3 · small_molecule · active

2 trials project

GSK4418959

Neoplasms, Colorectal

Phase 2 · small_molecule · active

1 trials project

IDE574

ER+, HER 2- Breast Cancer

Phase 2 · small_molecule · active

1 trials project

IDE849

Small-cell Lung Cancer

Phase 2 · small_molecule · active

1 trials project

IDE-161

Advanced or Metastatic Solid Tumors

Phase 1 · small_molecule · active

1 trials project

IDE034

Esophageal Squamous Cell Carcinoma

Phase 1 · small_molecule · active

1 trials project

IDE397

Solid Tumor

Phase 1 · small_molecule · active

1 trials project

IDE892

NSCLC Adenocarcinoma

Phase 1 · small_molecule · active

1 trials

Patents (8)

patent

US 12398131

Thiadiazolyl derivatives as DNA polymerase theta inhibitors and uses thereof

Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12269820

Piperazine substituted indazole compounds as inhibitors of PARG

Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12258354

AhR modulators

Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12115163

Combination therapy comprising a MAT2A inhibitor and a type II PRMT inhibitor

Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11584755

Dihydrothieno[3,2-b]pyridine compounds

Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11548867

Amido compounds as AhR modulators

Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11530220

Substituted imidazo[1,5-a]pyrazines and [1,2,4]triazolo[4,3-a]pyrazines for the

Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11407764

AhR modulators

Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)